BSEResultResults30 Jul 2026
Global Health Ltd
Result for the Quarter ended June 30, 2026
Global Health Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has reported a record date for the payment of final dividend for the financial year 2025-26, and has appointed a new Chief Digital Officer. The company has also approved a revised construction plan for its upcoming hospital at Guwahati, increasing the proposed bed capacity from 400 to 650 beds.
BSECompany UpdateResults30 Jul 2026
Global Health Ltd
Announcement regarding appointment of Mr. Pradeep Kumar Singh as one of the Senior Management Personnel.
Global Health Ltd has announced the appointment of Mr. Pradeep Kumar Singh as Chief Digital Officer and one of the Senior Management Personnel. The company has also approved the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The board has fixed the record date for the payment of final dividend for the financial year 2025-26, which will be paid to the shareholders within 30 days from the date of declaration. The company has also increased the proposed bed capacity of its upcoming hospital at Guwahati from 400 beds to 650 beds.
BSEBoard MeetingResults30 Jul 2026
Global Health Ltd
Outcome of Board Meeting held today i.e. July 30, 2026, to consider Unaudited Financial Results for Quarter ended June 30, 2026.
Global Health Ltd's board meeting outcome announced unaudited financial results for Q1 FY2026, approved revised construction plan for Guwahati hospital, and appointed Chief Digital Officer. The company also declared a final dividend of Rs. 0.50 per equity share for FY2025-26, subject to shareholder approval.
BSECompany Updateemployee_long_term_incentive30 Jul 2026
Global Health Ltd
It is informed that the Nomination & Remuneration Committee in its Meeting held on July 30, 2026, has made a grant of 20,000 ESOPs under GHL LTIP 2024
Global Health Ltd has informed about the grant of 20,000 ESOPs under GHL LTIP 2024 Plan to one employee. The ESOPs are exercisable within a maximum period of 3 years from the date of vesting of last instalment of Options under GHL LTIP 2024 Plan.
BSECompany UpdateResults24 Jul 2026
Global Health Ltd
Intimation for Earning Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
Global Health Ltd (Medanta) has scheduled an earnings conference call for Q1 FY2027 financial results on July 31, 2026, hosted by JM Financial.
BSECompany Update23 Jun 2026
Global Health Ltd
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
Global Health Ltd (Medanta) has informed about scheduled virtual one-on-one meetings with institutional investors, IKIGAI Asset Manager Holdings Private Limited and Enam Asset Management Company Private Limited, on June 26, 2026, and June 30, 2026, respectively. The company explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions, which are subject to change due to unforeseen circumstances.
BSECompany Update23 Jun 2026
Global Health Ltd
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
Global Health Ltd (Medanta) announced virtual one-to-one meetings with institutional investors, IKIGAI Asset Manager Holdings and Enam Asset Management Company, scheduled for June 26 and June 30, 2026, respectively. These meetings are held in compliance with SEBI Listing Regulations. The company explicitly stated that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during these interactions, and the schedule is subject to change.